Development of the Scalp Hair Assessment PRO™ measure for alopecia areata

The Alopecia Areata Investigator’s Global Assessment (AA‐IGA™) Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials

(2020) K.W. Wyrwich et al.   BRITISH JOURNAL OF DERMATOLOGY

Alopecia areata is associated with impaired health-related quality of life: a survey of affected adults and children, and their families

(2018) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Informing a priori Sample Size Estimation in Qualitative Concept Elicitation Interview Studies for Clinical Outcome Assessment Instrument Development

(2018) Diane M. Turner-Bowker et al.   VALUE IN HEALTH

Rethinking the classification of alopecia areata

(2018) C.G. Wambier et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Living with alopecia areata: An online qualitative survey study

(2018) L. Davey et al.   BRITISH JOURNAL OF DERMATOLOGY

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

(2017) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tofacitinib for the treatment of alopecia areata and variants in adolescents

(2017) Brittany G. Craiglow et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Alopecia areata and health-related quality of life: a systematic review and meta-analysis

(2016) F. Rencz et al.   BRITISH JOURNAL OF DERMATOLOGY

Health-related quality of life (HRQoL) among patients with alopecia areata (AA): A systematic review

(2016) Lucy Y. Liu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

The autoimmune basis of alopecia areata: A comprehensive review

(2015) Naseeha Islam et al.   AUTOIMMUNITY REVIEWS

Clinical Outcome Assessments: Conceptual Foundation—Report of the ISPOR Clinical Outcomes Assessment – Emerging Good Practices for Outcomes Research Task Force

(2015) Marc K. Walton et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument

(2011) Donald L. Patrick et al.   VALUE IN HEALTH